- Home
- IOVA vs MUC Comparison
IOVA vs MUC Comparison
Compare IOVA & MUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- MUC
- Stock Information
- Founded
- IOVA 2007
- MUC 1997
- Country
- IOVA United States
- MUC United States
- Employees
- IOVA N/A
- MUC N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- MUC Investment Bankers/Brokers/Service
- Sector
- IOVA Health Care
- MUC Finance
- Exchange
- IOVA Nasdaq
- MUC Nasdaq
- Market Cap
- IOVA 975.1M
- MUC 962.6M
- IPO Year
- IOVA N/A
- MUC N/A
- Fundamental
- Price
- IOVA $2.30
- MUC $10.78
- Analyst Decision
- IOVA Buy
- MUC
- Analyst Count
- IOVA 11
- MUC 0
- Target Price
- IOVA $11.90
- MUC N/A
- AVG Volume (30 Days)
- IOVA 10.8M
- MUC 292.8K
- Earning Date
- IOVA 11-06-2025
- MUC 01-01-0001
- Dividend Yield
- IOVA N/A
- MUC 4.19%
- EPS Growth
- IOVA N/A
- MUC N/A
- EPS
- IOVA N/A
- MUC N/A
- Revenue
- IOVA $241,525,000.00
- MUC N/A
- Revenue This Year
- IOVA $67.40
- MUC N/A
- Revenue Next Year
- IOVA $56.32
- MUC N/A
- P/E Ratio
- IOVA N/A
- MUC N/A
- Revenue Growth
- IOVA 636.99
- MUC N/A
- 52 Week Low
- IOVA $1.64
- MUC $9.19
- 52 Week High
- IOVA $12.51
- MUC $11.30
- Technical
- Relative Strength Index (RSI)
- IOVA 50.67
- MUC 52.60
- Support Level
- IOVA N/A
- MUC N/A
- Resistance Level
- IOVA $2.46
- MUC $10.86
- Average True Range (ATR)
- IOVA 0.14
- MUC 0.08
- MACD
- IOVA -0.09
- MUC -0.34
- Stochastic Oscillator
- IOVA 92.00
- MUC 99.22
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About MUC Blackrock MuniHoldings California Quality Fund Inc.
BlackRock MuniHoldings California Quality Fund Inc is a diversified, closed-end management investment firm. The investment objective of the company is to provide shareholders with current income exempt from U.S. federal income taxes and California personal income taxes.